KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $140.4 million.

  • Evolent Health's Cash & Current Investments rose 2431.95% to $140.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.4 million, marking a year-over-year increase of 2431.95%. This contributed to the annual value of $163.5 million for FY2024, which is 2085.99% down from last year.
  • Per Evolent Health's latest filing, its Cash & Current Investments stood at $140.4 million for Q3 2025, which was up 2431.95% from $175.4 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Cash & Current Investments ranged from a high of $342.0 million in Q4 2021 and a low of $112.9 million during Q3 2024
  • Its 5-year average for Cash & Current Investments is $210.7 million, with a median of $206.6 million in 2023.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 13661.95% in 2021, then plummeted by 4564.18% in 2024.
  • Quarter analysis of 5 years shows Evolent Health's Cash & Current Investments stood at $342.0 million in 2021, then tumbled by 40.73% to $202.7 million in 2022, then increased by 1.92% to $206.6 million in 2023, then decreased by 20.86% to $163.5 million in 2024, then decreased by 14.13% to $140.4 million in 2025.
  • Its Cash & Current Investments was $140.4 million in Q3 2025, compared to $175.4 million in Q2 2025 and $262.8 million in Q1 2025.